Gil M Labrucherie - Net Worth and Insider Trading
Gil M Labrucherie Net Worth
The estimated net worth of Gil M Labrucherie is at least $769,005 dollars as of 2025-03-26. Gil M Labrucherie is the Director of Rezolute Inc and owns about 99,673 shares of Rezolute Inc (RZLT) stock worth over $278,088. Gil M Labrucherie is the CFO of Septerna Inc and owns about 40,000 shares of Septerna Inc (SEPN) stock worth over $245,600. Gil M Labrucherie is also the SVP, COO & CFO of Nektar Therapeutics and owns about 312,905 shares of Nektar Therapeutics (NKTR) stock worth over $245,318. Details can be seen in Gil M Labrucherie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gil M Labrucherie has not made any transactions after 2025-02-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gil M Labrucherie
Gil M Labrucherie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gil M Labrucherie owns 3 companies in total, including Nektar Therapeutics (NKTR) , Rezolute Inc (RZLT) , and Acelyrin Inc (SLRN) .
Click here to see the complete history of Gil M Labrucherie’s form 4 insider trades.
Insider Ownership Summary of Gil M Labrucherie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2022-05-16 | SVP & COO & CFO |
| RZLT | Rezolute Inc | 2022-05-04 | director |
| SLRN | Acelyrin Inc | 2023-08-02 | Interim CFO |
Gil M Labrucherie Latest Holdings Summary
Gil M Labrucherie currently owns a total of 3 stocks. Among these stocks, Gil M Labrucherie owns 99,673 shares of Rezolute Inc (RZLT) as of May 4, 2022, with a value of $278,088 and a weighting of 36.16%. Gil M Labrucherie owns 40,000 shares of Septerna Inc (SEPN) as of February 27, 2025, with a value of $245,600 and a weighting of 31.94%. Gil M Labrucherie also owns 312,905 shares of Nektar Therapeutics (NKTR) as of May 16, 2022, with a value of $245,318 and a weighting of 31.9%.
Latest Holdings of Gil M Labrucherie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RZLT | Rezolute Inc | 2022-05-04 | 99,673 | 2.79 | 278,088 |
| SEPN | Septerna Inc | 2025-02-27 | 40,000 | 6.14 | 245,600 |
| NKTR | Nektar Therapeutics | 2022-05-16 | 312,905 | 0.78 | 245,318 |
Holding Weightings of Gil M Labrucherie
Gil M Labrucherie Form 4 Trading Tracker
According to the SEC Form 4 filings, Gil M Labrucherie has made a total of 2 transactions in Rezolute Inc (RZLT) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Rezolute Inc is the acquisition of 52,631 shares on May 4, 2022, which cost Gil M Labrucherie around $199,998.
According to the SEC Form 4 filings, Gil M Labrucherie has made a total of 2 transactions in Septerna Inc (SEPN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Septerna Inc is the acquisition of 10,000 shares on February 27, 2025, which cost Gil M Labrucherie around $56,900.
According to the SEC Form 4 filings, Gil M Labrucherie has made a total of 11 transactions in Nektar Therapeutics (NKTR) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Nektar Therapeutics is the sale of 17,448 shares on May 16, 2022, which brought Gil M Labrucherie around $68,920.
Insider Trading History of Gil M Labrucherie
- 1
Gil M Labrucherie Trading Performance
GuruFocus tracks the stock performance after each of Gil M Labrucherie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gil M Labrucherie is -15.12%. GuruFocus also compares Gil M Labrucherie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gil M Labrucherie within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gil M Labrucherie's insider trading performs compared to the benchmark.
Performance of Gil M Labrucherie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -9.63 | | | | | |
| Relative Return to S&P 500(%) | -5.56 | | | | | |
Gil M Labrucherie Ownership Network
Ownership Network List of Gil M Labrucherie
Ownership Network Relation of Gil M Labrucherie
Gil M Labrucherie Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Gil M Labrucherie is the SVP & COO & CFO of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Gil M Labrucherie made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 243,523 shares made by Howard W Robin , a net sale of 102,081 shares made by Jonathan Zalevsky , and a net sale of 94,105 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 45,114 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 45,114 shares. During the past 18 months, 515,209 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 515,209 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Gil M Labrucherie Mailing Address
Above is the net worth, insider trading, and ownership report for Gil M Labrucherie. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Gil M Labrucherie's mailing address is: San Carlos Ca 94070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
